RecruitingNot ApplicableNCT04678583
Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer
Sponsor
Technische Universität Dresden
Enrollment
240 participants
Start Date
Jan 1, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is comparing two types of liver surgery — anatomical resection (removing a defined segment of the liver) versus non-anatomical resection (removing just the tumor and a margin around it) — in patients with colorectal cancer that has spread to the liver and carries a specific gene mutation (RAS mutation). Researchers want to determine which surgical approach leads to better long-term cancer control.
**You may be eligible if you:**
- Have colorectal cancer with a RAS mutation (KRAS or NRAS)
- Have cancer that has spread to the liver (liver metastases)
- Are planned for surgery to remove all liver tumors completely (R0 resection)
- Both anatomical and non-anatomical liver surgery are technically possible for your case
- Are 18 years of age or older
**You may NOT be eligible if you:**
- Have cancer spread outside the liver (e.g., to the lungs)
- Are planned for a staged liver resection (two separate surgeries)
- Have been diagnosed with another cancer in the past 5 years (with some exceptions)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREResection of colorectal liver metastases
Comparison of two liver surgery methods
Locations(37)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04678583